Back to Search
WILSON TONG, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1427261437IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A116219(CA)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
40846(AZ)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE
Class of 2007
Research & Publications (20)
Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor.
PMID 19682743·Leuk Res·2010
8-other
Partial order optimum likelihood (POOL): maximum likelihood prediction of protein active site residues using 3D Structure and sequence properties.
PMID 19148270·PLoS Comput Biol·2009
7-preclinical
Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.
PMID 17637498·Exp Hematol·2007
7-preclinical
Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
PMID 17414622·Anticancer Drugs·2007
8-other
Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice.
PMID 17160013·Oncogene·2007
7-preclinical
The membrane-proximal region of the thrombopoietin receptor confers its high surface expression by JAK2-dependent and -independent mechanisms.
PMID 17052978·J Biol Chem·2006
8-other
Equilibrium distribution of permeants in polyelectrolyte microcapsules filled with negatively charged polyelectrolyte: the influence of ionic strength and solvent polarity.
PMID 16805590·J Phys Chem B·2006
8-other
In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
PMID 16987639·Int J Antimicrob Agents·2006
8-other
Aflatoxin-B exposure does not lead to p53 mutations but results in enhanced liver cancer of Hupki (human p53 knock-in) mice.
PMID 16557586·Int J Cancer·2006
7-preclinical
Evaluation of external RNA controls for the assessment of microarray performance.
PMID 16964227·Nat Biotechnol·2006
8-other
Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
PMID 15705783·Blood·2005
7-preclinical
LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways.
PMID 16105664·Biochem Biophys Res Commun·2005
8-other
Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation.
PMID 15688149·Int J Colorectal Dis·2005
8-other
Age, gender and metabolic syndrome-related coronary heart disease in U.S. adults.
PMID 16186058·Int J Cardiol·2005
4-observational
Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
PMID 15337790·J Exp Med·2004
7-preclinical
Assessment of prediction confidence and domain extrapolation of two structure-activity relationship models for predicting estrogen receptor binding activity.
PMID 15345371·Environ Health Perspect·2004
7-preclinical
[Study on distribution of interstitial cells of Cajal in the sigmoid colon of patients with slow transit constipation].
PMID 15363273·Zhonghua Wai Ke Za Zhi·2004
8-other
Using decision forest to classify prostate cancer samples on the basis of SELDI-TOF MS data: assessing chance correlation and prediction confidence.
PMID 15598613·Environ Health Perspect·2004
8-other
Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!
PMID 15620124·Postgrad Med·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4721 DALLAS RANCH RD
ANTIOCH, CA 94531 - Phone
- (925) 778-0679
Quick Facts
- NPI
- 1427261437
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile